The prevention of transfusion-associated circulatory overload

Transfusion Medicine Reviews

Volumn 27, Issue 2, 2013, Pages 105-112

  Alam, Asim ^a,b,c   Lin, Yulia ^a,b,c   Lima, Ana ^a,b,c   Hansen, Mark ^a,b,c   Callum, Jeannie L ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTICOAGULANT AGENT; CAPTOPRIL; DIURETIC AGENT; FRESH FROZEN PLASMA; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE; LEVOSIMENDAN; NESIRITIDE; PROTHROMBIN COMPLEX; RAMIPRIL; TEZOSENTAN;

ACUTE HEART INFARCTION; BLOOD TRANSFUSION REACTION; CLINICAL SUPERVISION; CONGESTIVE HEART FAILURE; DIASTOLIC HEART FAILURE; DISEASE SEVERITY; DRUG DOSE COMPARISON; ECHOCARDIOGRAPHY; ERYTHROCYTE TRANSFUSION; FLUID BALANCE; HEALTH CARE PERSONNEL; HEART LEFT VENTRICLE FAILURE; HEART STRESS; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INFUSION PUMP; INTENSIVE CARE UNIT; KIDNEY FAILURE; LEADERSHIP; LENGTH OF STAY; LUNG EDEMA; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT MONITORING; PLASMA TRANSFUSION; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION RELATED ACUTE LUNG INJURY;

AGE FACTORS; BLOOD CIRCULATION; BLOOD TRANSFUSION; CRITICAL CARE; HEART FAILURE; HUMANS; INCIDENCE; PULMONARY EDEMA; RISK FACTORS; WATER-ELECTROLYTE BALANCE;

EID: 84876119230     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2013.02.001     Document Type: Review

References (56)

1. Popovsky M.A. Transfusion-associated circulatory overload. ISBT Sci Series 2008, 3:166-169.
2. Skeate R.C., Eastlund T. Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Curr Opin Hematol. 2007, 14:682-687.
3. Tobian A.A.R., Sokoll L.J., Tisch D.J., Ness P.M., Shan H. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion 2008, 48:1143-1150.
4. Li G., Rachmale S., Kojicic M., Shahjehan K., Malinchoc M., Kor J., et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion 2011, 51:338-343.
5. Zhou L., Giacherio D., Cooling L., Davenport R.D. Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion 2005, 45:1056-1063.
6. Canada PHAO. Transfusion Transmitted Injuries Surveillance System. Government of Canada; 2011. Available from: http://www.phac-aspc.gc.ca/hcai-iamss/tti-it/ttiss_users_manual/index-eng.php.
7. Robillard P., Hyson C., McCombie N. TRALI, possible TRALI and respiratory complications of transfusion reported to the Canadian Transfusion-Transmitted Injuries Surveillance System. Transfusion 2007, Suppl 47(35):47. 5A.
8. Robillard P., Itaj N.K., Chapdelaine A. Five-year trends in the incidence of serious adverse transfusion reactions in the Quebec haemovigillance system (abstract). Transfusion; 2006, 46:86A.
9. David B. Haemovigilance: A comparison of three national systems. 27th Congress of the International Society of, Blood Transfusion; 2002.
10. Narick C., Triulzi D.J., Yazer M.H. Transfusion-associated circulatory overload after plasma transfusion. Transfusion 2012, 52:160-165.
11. Fatalities Reported to FDA Following Blood Collection and Transfusion. 2012;1-12. Available from: http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm302847.htm.
12. Serious Hazards of Transfusion. Annual SHOT Report 2011. 2012;Available from: http://www.shotuk.org/shot-reports/shot-annual-report-summary-2011/.
13. Rana R., Fernández Pérez E.R., Khan S.A., Rana S., Winters J.L., Lesnick T.G., et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006, 46:1478-1483.
14. Finlay H.E., Cassorala L., Feiner J., Toy P. Designing and testing a computer-based screening system for transfusion-related acute lung injury. Am J Clin Pathol 2005, 124:601-609.
15. Bierbaum B.E.B., Callaghan J.J.J., Galante J.O.J., Rubash H.E.H., Tooms R.E.R., Welch R.B.R. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999, 81:2-10.
16. Popovsky M.A. Transfusion and the lung: circulatory overload and acute lung injury. Vox Sang 2004, 87:62-65.
17. Popovsky M.A. Pulmonary consequences of transfusion: TRALI and TACO. Transfus Apher Sci. 2006, 34:243-244.
18. Popovsky M.A., Audet A.M., Andrzejewski C. Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study. Immunohematology 1996, 12:87-89.
19. Li G., Daniels C.E., Kojicic M., Krpata T., Wilson G.A., Winters J.L., et al. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion 2009, 49:13-20.
20. Robillard P., Itaj N.K., Chapdelaine A. Increasing incidence of transfusion associated circulatory overload reported to the Quebec Hemovigilance System, 2000-2006. Transfusion 2008, 48:212.
21. Gottdiener J.S., Arnold A.M., Aurigemma G.P., Polak J.F., Tracy R.P., Kitzman D.W., et al. Predictors of congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol. 2000, 35:1628-1637.
22. Bursi F., Weston S.A., Redfield M.M., Jacobsen S.J., Pakhomov S., Nkomo V.T., et al. Systolic and diastolic heart failure in the community. JAMA 2006, 296(8):2209-2216.
23. Kenchaiah S., Narula J., Vasan R.S. Risk factors for heart failure. Med Clin North Am. 2004, 88:1145-1172.
24. Abraham J., Abraham T.P. The role of echocardiography in hemodynamic assessment in heart failure. Heart Fail Clin 2009, 5:191-208.
25. Kalogeropoulos A.P., Georgiopoulou V.V., de Filippi C.R., Gottdiener J.S., Butler J. Cardiovascular Health Study. Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study. JACC Cardiovasc Imaging 2012, 5:131-140.
26. Cooper H.A., Rao S.V., Greenberg M.D., Rumsey M.P., McKenzie M., Alcorn K.W., et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol. 2011, 108:1108-1111.
27. Goodnough L.T., Shander A. How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage. Blood 2011, 117:6091-6099.
28. Lankiewicz M.W., Hays J., Friedman K.D., Tinkoff G., Blatt P.M. Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost. 2006, 4:967-970.
29. National Blood Users Group. Guidelines for the Administration of Blood and Blood Components. 2004: 1-29.
30. Larsen G.Y., Mecham N., Greenberg R. An emergency department septic shock protocol and care guideline for children initiated at triage. Pediatrics 2011, 127:e1585-e1592.
31. Gurnani P.K., Patel G.P., Crank C.W., Vais D., Lateef O., Akimov S., et al. Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: a single-center, before-and-after study. Clin Ther 2010, 32:1285-1293.
32. Wakefield D.S., Ward M.M., Groath D., Schwichtenberg T., Magdits L., Brokel J., et al. Complexity of medication-related verbal orders. Am J Med Qual 2008, 23:7-17.
33. Sorokin R., Claves J.L., Kane G.C. The near miss resident conference: understanding the barriers to confronting medical errors 2002, Semin, Med Pract.
34. John D Roback MDPD, Brenda J Grossman MD, Harris T, Hillyer CD. Technical Manual. 17(null) ed. Bethesda: American Association of Blood Banks (AABB); 2011.
35. Brecher M.E. Technical Manual 2005, S Karger Pub, Bethesda. 17(null) ed.
36. Gupta S.P., Nand N., Gupta M.S. Left ventricular filling pressures after rapid blood transfusion in cases of chronic severe anemia. Angiology 1982, 33:343-348.
37. Nand N., Gupta M.S., Bhutani J.C., Gupta S.P., Sharma M. A comparative study of conventional vs rapid speed of blood transfusion in cases of chronic severe anemia. Angiology 1985, 36:617-621.
38. Reece R.L., Beckett R.S. Epidemiology of single-unit transfusion. A one-year experience in a community hospital. JAMA 1966, 195:801-816.
39. Micolonghi T., Simon S., Paull A. The single-unit transfusion in a community hospital-a critical evaluation. Improved blood transfusion practices may result in increased incidence of single-unit transfusions. R I Med J 1966, 49:533-536.
40. Practice strategies for elective red blood cell transfusion American College of Physicians. Ann Intern Med 1992, 116:403-406.
41. Carson J.L., Terrin M.L., Magaziner J., Chaitman B.R., Apple F.S., Heck D.A., et al. Transfusion trigger trial for functional outcomes in cardiovascular patients undergoing surgical hip fracture repair (FOCUS). Transfusion 2006, 46:2192-2206.
42. Lacroix J., Hébert P.C., Hutchison J.S., Hume H.A., Tucci M., Ducruet T., et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007, 356:1609-1619.
43. Hajjar L.A., Vincent J.L., Galas F.R., Nakamura R.E., Silva C.M., Santos M.H., et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010, 304:1559-1567.
44. Ma M., Eckert K., Ralley F., Chin-Yee I. A retrospective study evaluating single-unit red blood cell transfusions in reducing allogeneic blood exposure. Transfus Med 2005, 15:307-312.
45. Wargo K.A., Banta W.M. A comprehensive review of the loop diuretics: should furosemide be first line?. Ann Pharmacother. 2009, 43:1836-1847.
46. Gupta S.P., Nand N., Gupta M.S., Mohan J.C. Haemodynamic changes following blood transfusion in cases of chronic severe anemia: increased safety with simultaneous furosemide administration. Angiology 1983, 34:699-704.
47. Balegar KK V, Kluckow M. Furosemide for packed red cell transfusion in preterm infants: a randomized controlled trial. J Pediatr 2011;159:913-8.e1.
48. Fry J.L., Arnold D.M., Clase C.M., Crowther M.A., Holbrook A.M., Traore A.N., et al. Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices. Transfusion 2010, 50:1722-1730.
49. Agrawal A.K., Hsu E., Quirolo K., Neumayr L.D., Flori H.R. Red blood cell transfusion in pediatric patients with severe chronic anemia: how slow is necessary?. Pediatr Blood Cancer 2012, 58:466-468.
50. Callum JL. The characteristics of transfusion associated circulatory overload patients at two hospitals in Toronto, Ontario. Medicine & Tissue Banks Sunnybrook Health Sciences Centre B211, 2075 Bayview Avenue, Toronto, ON, M4N 3M5.
51. Contreras M., Taylor C.P., Barbara J.A. Postgraduate Haematology 2010, Wiley-Blackwell, Oxford, UK. 6th ed.
52. Teerlink J.R. Overview of randomized clinical trials in acute heart failure syndromes. Am J Cardiol. 2005, 96:59G-67G.
53. Wilkinson J., Wilkinson C. Administration of blood transfusions to adults in general hospital settings: a review of the literature. J Clin Nurs 2001, 10:161-170.
54. Adams K.W., Tolich D. Blood transfusion: the patient's experience. Am J Nurs. 2011, 111:24-30.
55. Andrzejewski C., Popovsky M.A., Stec T. Measured and derived vital sign values in transfusion reactions associated with fluid challenges (abstract). Transfusion 2008, 48:212A.
56. Andrzejewski C., Popovsky M.A., Stec T.C., Provencher J., O'Hearn L., Visintainer P., et al. Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory aspects?. Transfusion 2012, 52:2310-2320.